General information | DisProt: | DP00521 | Name: | Securin | Synonym(s): | PTTG1_HUMAN
Pituitary tumor-transforming gene 1 protein
hPTTG
Tumor-transforming protein 1
Esp1-associated protein
| First appeared in release: | Release 3.5 (12/22/2006) | UniProt: | O95997 | UniGene: | Hs.350966 | SwissProt: | PTTG1_HUMAN | TrEMBL: | | NCBI (GI): | 29336594 | Source organism: | Homo sapiens (Human) | Sequence length: | 202 | Percent disordered: | 100% | Homologues: | |
Native sequence |
10 20 30 40 50 60 | | | | | | MATLIYVDKE NGEPGTRVVA KDGLKLGSGP SIKALDGRSQ VSTPRFGKTF DAPPALPKAT - 60 RKALGTVNRA TEKSVKTKGP LKQKQPSFSA KKMTEKTVKA KSSVPASDDA YPEIEKFFPF - 120 NPLDFESFDL PEEHQIAHLP LSGVPLMILD EERELEKLFQ LGPPSPVKMP SPPWESNLLQ - 180 SPSSILSTLD VELPPVCCDI DI
|
Functional narrative |
Regulatory protein, which plays a central role in chromosome stability, in the p53/TP53 pathway, and DNA repair. Probably acts by blocking the action of key proteins. During the mitosis, it blocks Separase/ESPL1 function, preventing the proteolysis of the cohesin complex and the subsequent segregation of the chromosomes. At the onset of anaphase, it is ubiquitinated, conducting to its destruction and to the liberation of ESPL1. Its function is however not limited to a blocking activity, since it is required to activate ESPL1. Negatively regulates the transcriptional activity and related apoptosis activity of TP53. The negative regulation of TP53 may explain the strong transforming capability of the protein when it is overexpressed. May also play a role in DNA repair via its interaction with Ku, possibly by connecting DNA damage-response pathways with sister chromatid separation.
|
Map of ordered and disordered regions |
Note: 'Mouse' over a region to see the start and stop residues. Click on a region to see detailed information.
|
Region 1 | Type: | Disordered | Name: | | Location: | 1 - 202 | Length: | 202 | Region sequence: |
MATLIYVDKENGEPGTRVVAKDGLKLGSGPSIKALDGRSQVSTPRFGKTFDAPPALPKAT RKALGTVNRATEKSVKTKGPLKQKQPSFSAKKMTEKTVKAKSSVPASDDAYPEIEKFFPF NPLDFESFDLPEEHQIAHLPLSGVPLMILDEERELEKLFQLGPPSPVKMPSPPWESNLLQ SPSSILSTLDVELPPVCCDIDI | Modification type: | Monomeric
Native
| PDB: | | Structural/functional type: | Function arises from the disordered state Function arises via a disorder to order transition | Functional classes: | Modification site
Molecular recognition effectors
| Functional subclasses: | Phosphorylation
Protein-DNA binding
Apoptosis Regulation
Protein-protein binding
| Detection methods:
- Size exclusion/gel filtration chromatography (pH: 7.2; 2-mercaptoethanol (buffer) 10 mM; KCl (buffer) 150 mM; phosphate (buffer) 25 mM; securin (sample) 100 microM; Superdex 200 HR10/30 column)
- Circular dichroism (CD) spectroscopy, far-UV (pH: 7.2; 1-mm pathlength; DTE (buffer) 1 mM; KCl (buffer) 150 mM; NaPi (buffer) 25 mM; protein (sample) 10 microM)
- Analytical ultracentrifugation (283 K; )
- Nuclear magnetic resonance (NMR) (293 K; pH: 7.2; 2-mercaptoethanol 10 mM; KCl 150 mM; NaP 25 mM)
| References:
- Sanchez-Puig N, Veprintsev DB, Fersht AR. "Human full-length Securin is a natively unfolded protein." Protein Sci. 2005; 14(6): 1410-8. PubMed: 15929994
| Comments:
|
If you have any comments or wish to provide additional references to this protein or its disordered region(s), please click here to e-mail us. |
Disprot-footer
|